noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Politics and Policy

Pharmaceuticals and Biotechnology

NACDS - National Association of Chain Drug Stores Inc.

10/29/2026 | Press release | Distributed by Public on 10/29/2026 09:39

Plus, Anderson joins a Milken Institute Future of Health Summit panel on Nov. 13.

GLP-1 medications are changing how the nation approaches obesity and chronic disease. For patients, the local pharmacy can be a trusted partner every step of the way.

In an essay published this week by the Milken Institute, NACDS President and CEO Steven C. Anderson previews the Institute's forthcoming report, supported by NACDS, on how pharmacy teams can help patients use GLP-1s safely and successfully. "A prescription is a beginning, not a finish line," Anderson writes.

NACDS - National Association of Chain Drug Stores Inc. published this content on October 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 29, 2026 at 15:39 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format